DMAA
NASDAQ · N/A
Drugs Made In America Acquis
$10.90
+0.00 (+0.00%)
Open$10.91
Previous Close$10.90
Day High$10.91
Day Low$10.90
52W High$10.91
52W Low$10.31
Volume—
Avg Volume9.6K
Market Cap264.62M
P/E Ratio43.42
EPS$0.21
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.69M | 205.61M | 216.54M |
| Net Income | 25.03M | 23.39M | 21.58M |
| Profit Margin | 11.4% | 11.4% | 10.0% |
| EBITDA | 37.03M | 38.19M | 42.37M |
| Free Cash Flow | 19.51M | 14.22M | 14.32M |
| Rev Growth | -5.7% | -2.0% | +21.2% |
| Debt/Equity | 0.87 | 0.86 | 1.14 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.75 | -20.08% | — | 585.99M |
| PICS | Pics Nv | $6.89 | -7.14% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.20% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.62 | +0.05% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.35 | +0.19% | 41.5 | 590.36M |